NASDAQ •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 06/18/2026 16:00
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization12.8 mln
Float8.06 mln
Earnings Date08/07/2026
Piotroski F-Score
3
/ 9
Below average
Beneish M-Score
0.65
Highly suspicious
1-Year Forecast
5.88
Transformational upside
Relative Strength
42
/ 100
Slightly lagging
Debt / Equity
1.27
Elevated leverage
ROE
-567
Deeply negative
Business Description
Biofrontera is a US-based company focused on bringing specialized skin care treatments to market. Its main product, Ameluz, is used alongside a proprietary lamp system to treat actinic keratosis, a condition where sun-damaged skin develops lesions that can become cancerous if left untreated. Founded in 2015 and operating out of Woburn, Massachusetts, the company works to make these treatments available to patients across the country.
